The purpose of this study was to assess the consistency of decision-making among consultant urologists in the management of early prostate cancer. Thirty-two UK urology consultants completed a questionnaire containing 70 paper scenarios representing patients with early prostate cancer. Within these were 13 repeat cases to allow assessment of reliability of decision-making. Consultants demonstrated low reliability (on average 56-79%) when formulating decisions. None of the consultants used all of the available patient information when formulating treatment plans. The cue 'patient choice' was not used significantly by any of the consultants and the cue 'patient comorbidity' was rarely used despite being crucial components of decision-making. These results are surprising and in general represent poor clinical practice. They also justify the increasing use of the multidisciplinary team and protocol-driven pathways to standardize and thus improve patient care.
Introduction
To make appropriate management decisions for individual patients, clinicians must assimilate numerous medical facts and incorporate patient choice. To optimize decision-making, judgements must be made on the basis of information regarding the patient, in addition to the clinician's own knowledge and experience. These clinical decisions are complex judgements involving vast quantities of information. During the process of decisionmaking, each clinician assimilates data in their own way before placing emphasis on particular factors to make clinical judgements.
Judgement analysis (JA) is a method used to describe, quantitatively, the relationship between a person's judgement and the information ('cues') used to make that judgement, that is it is a set of principles used to analyse complex decision-making processes. 1 JA has been applied extensively in fields such as child psychology, industrial processes, medical 2 and political decisionmaking. In medicine, JA has been used most notably by Kirwan et al. [3] [4] [5] [6] who published a series of studies investigating decision-making in the management of rheumatoid arthritis. Kirwan studied two consultant rheumatologists and found that they did not adopt a uniform underlying policy for the assessment of changes in disease activity, with each consultant having their own approach to making such judgements. Kirwan also found varying consistency in judgements, leading to disagreement even when underlying policies were similar. In addition, this study gave an insight into the discrepancy between how clinicians perceived their use of patient information (cues) and how they actually used the cues in clinical practice to make management decisions.
The aim of our study was to investigate aspects of clinician decision-making in the management of early prostate cancer. We aimed to assess consistency by individual clinicians (intra-observer reliability) and between clinicians (inter-observer reliability). We also aimed to use JA techniques to determine which cues were used in decision-making in the management of early prostate cancer and how the cues were used. By studying the different ways in which consultant urologists reach decisions in the management of early prostate cancer, we aimed to explain why the management of similar patients can be variable and inconsistent. By dissecting the decision-making process we hoped to facilitate decision-making in the clinic and multidisciplinary team (MDT) meeting setting and thus ultimately to improve the consistency and appropriateness of our decisions and patient care.
Methods
A total of 120 consultants from hospitals in England and Wales were selected at random from a comprehensive list of practicing consultants on the British Association of Urological Surgeons database.
7 Thirty-two consultants agreed to participate and completed a questionnaire containing 70 case scenarios (described below). The consultants were on average 8.3 years into their consultant posts (range 1-18). Eighteen of the consultants regularly conducted radical prostatectomies and all routinely dealt with early prostate cancer patients, making decisions to either refer them for treatment or conduct the treatment themselves. Nineteen consultants were employed in district general hospitals and thirteen in teaching hospitals.
To perform a JA, sets of information (cues) must be assessed by the group of individuals under investigation. 8 In our study the cues under investigation were pieces of information used in the management of localized prostate cancer and the individuals were consultant urologists. A list of potential cues was reviewed by local consultant urologists all of whom regularly make management decisions for patients with early prostate cancer. Irrelevant cues were excluded leaving seven cues that were considered vital for decision-making in the management of early prostate cancer. Interestingly, research has indicated that expert judges (in this case consultant urologists) very rarely use more than seven cues to form a judgement. 9 The cues used in this study were prostate-specific antigen (PSA), combined Gleason score, digital rectal examination (DRE), other staging information (four categories, for example disease contained within prostate, extra-capsular spread), patient treatment preference (five categories reflecting increasing risk avoidance), age and co-morbidity. Co-morbidity data were felt to be particularly useful to urologists since they often deal with elderly men with multiple co-morbidities and treatment options often vary according to perceived life expectancy. In the case scenarios, co-morbidity was presented in text form giving relevant information on (for example) hypertension, diabetes and so on; for the purposes of analysis, this was converted to life expectancy in years based on actuarial data. 10 A computer program was then used to randomly generate 500 'paper' case scenarios using the cues listed above. The 500 paper cases were subsequently reviewed by three consultant urologists. Cases not representative of patients with early prostate cancer were excluded leaving a total of 57 cases (patient scenarios) to be used in the study. Case scenarios (13 of 57) were duplicated and hidden randomly with the series, making a total of 70 cases. The duplication was performed to allow assessment of consistency of decision-making.
The 70 paper case scenarios were presented to 32 consultants in a format similar to that used in MDT meetings (Table 1) . Each consultant was asked to record how strongly they would advise each of the standard treatments for early prostate cancer (radical prostatectomy, radiotherapy and hormones/active surveillance), for each of the 70 cases. Their strength of preference for a particular treatment was recorded on a 10 cm Likert scale (0 representing 'would not advise' the treatment option, ranging to 10, representing 'would strongly advise'). Completion of the patient scenarios was supervised by JW and a full explanation of the data representation and scoring system was given to each consultant.
Statistics
As shown in the examples below, the Likert scores for the case scenarios were converted into fractional scores. This was necessary to standardize the results to allow comparison of the strength of preference of treatments between consultants. For example, in a particular scenario, if a consultant had marked his strength of preference on the visual analog scale at 6 cm for prostatectomy, 2 cm for radiotherapy and 1 cm for conservative treatment, the total points allocated would equal 6 þ 2 þ 2 ¼ 10. His strength of preference would therefore be 6/10 ¼ 0.6 for prostatectomy, 2/10 ¼ 0.2 for radiotherapy and 2/10 ¼ 0.2 for conservative therapy. Taking a second example, if the scores were recorded at 9 cm for prostatectomy, 8 cm for radiotherapy and 2 cm for conservative therapy, the total points allocated would be 9 þ 8 þ 2 ¼ 21. The fractional scores would therefore be 9/21 ¼ 0.43, 8/21 ¼ 0.38 and 2/21 ¼ 0.09.
To assess reliability of decision-making, 13 duplicate cases were placed at random throughout the 70 paper case scenarios. The judgements made on these repeat case pairs were then analysed by calculating standard intra-observer reliability coefficients based on components of variance. Inter-observer reliabilities for the series of consultant decisions were also studied. These reliabilities were calculated using analysis of variance components on all 70 case scenarios.
Spearman's correlation coefficients between each cue and treatment option were calculated for each 
Results

Reliability
The reliability of decision-making for each consultant varied enormously (Figure 1 ): for radical prostatectomy intra-observer reliability for each of the 32 consultants ranged from 41 to 100%, with an overall figure of 79%; for radiotherapy the range was 0-89%, overall 56%; and for hormones/active surveillance 19-94%, overall 67%.
Interestingly, intra-observer reliability was not statistically significantly correlated with years as a consultant (P ¼ 0.097), type of hospital (teaching hospital or district general) (P ¼ 0.064) or whether the consultant personally performed radical prostatectomy (P ¼ 0.303). Interobserver reliability was 57% for prostatectomy, 24% for radiotherapy and 41% for hormone therapy.
On further detailed review of the raw data we discovered two main patterns of decision-making. Group A (six consultants) followed a polarized pattern of decision-making, often scoring either 0 or 10 on the Likert scale, indicating that they would either not recommend a treatment or would very strongly recommend it. This was particularly obvious when considering radical prostatectomy, indicating that these consultants made very definitive decisions when considering radical prostatectomy. Group B (26 consultants) followed a more diverse pattern of decision-making with less polarized decisions. 
Cue use
Although every consultant was given identical information to aid decision-making, individuals were found to use different aspects of this information when formulating their judgements, as judged by whether there was significant (Po0.01) correlation between any particular piece of information (cue) and strength of recommendation for treatment (Figure 2 ). On no occasions were all cues used significantly. When recommending prostatectomy, the cues most commonly used were DRE, stage and PSA. These were used significantly by 94, 90 and 84% of the consultants respectively. When advising hormones/ active surveillance the cues most commonly used were age (63%), DRE (56%) and stage (53%). When recommending radical radiotherapy, Gleason score, DRE and age were used most commonly (44, 25 and 19% respectively). However, as can be seen in Figure 2 , overall cue use was substantially lower when recommending this treatment modality than for either radical prostatectomy or radiotherapy. Importantly, we found that some cues were rarely used in decision-making. Patient choice was not used significantly by any of the consultants when recommending any of the treatment modalities. Furthermore, co-morbidity was used by only one consultant when suggesting radical radiotherapy and one consultant when advising hormone/conservative therapy, but by none when recommending radical prostatectomy.
Discussion
This study has revealed two main issues. First, that consultants demonstrated poor reliability when formulating treatment plans and second that they used only a small proportion of the available patient information when making these decisions. The credibility of these results rests on the extent to which the completion of the case scenarios mirrors the actual decision-making process when real patients are involved. While it is possible that the consultants involved gave less consideration to these fictitious patients than they would to real patients, there are a number of reasons why we think this unlikely: the consultants were volunteers who were aware of the time required to complete the exercise; the questionnaire was explained clearly to the consultants and completed in the presence of JW with no time limit; under these 'test' conditions it might be considered that the consultants would in fact be more likely to be consistent by wanting to provide 'correct answers'; paper case representations have been shown to be a valid alternative to 'real' patients for the purposes of collecting judgements as reported by Kirwan et al.
3 who demonstrated a high correlation between judgements by rheumatologists for 'real' patients and those for 'paper' patients; increasingly, clinicians are required to formulate treatment plans when they have had little direct contact with, and minimal knowledge of the patients themselves, for example MDT meetings.
Reliability
The consultants demonstrated poor reliability of judgements, both within and between individuals. This is clinically relevant as it suggests that patients may be offered entirely different treatments if their case was discussed by different clinicians or even by the same clinician at a different time. In this study, intra-observer reliability was greatest when recommending radical prostatectomy and least when advising radiotherapy. Perhaps consultant urologists do not feel confident in recommending radiotherapy as they are not directly involved in administering this treatment. It is also interesting to note that we did not find any significant correlation between intra-observer reliability and years as a consultant, type of hospital (teaching hospital or district general) or whether the consultant personally performed radical prostatectomy.
If the poor reliability of decision-making demonstrated in our study is a true representation of what occurs in the clinical environment, several aspects of the management of early prostate cancer could be improved. This includes standardization of management through the use of protocols and ongoing training for clinicians. This research also further justifies the use of the MDT which Hormones /Active Surveillance Figure 2 Graph to show number of consultants out of 32 'using' cues significantly (Po0.01) when formulating treatment decisions.
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by incorporating the opinion of multiple specialists from different fields should minimize individual bias and improve both the process of decision-making and its reliability.
Cue use
It is reasonable to assume that clinicians would use all available information when formulating treatment decisions. However, this study reveals that in reality, clinicians use only a small proportion of clinical information (that is few cues) when making decision. Previous research by Miller et al. 5 revealed that individuals should be able to assimilate a maximum of seven pieces of information in a decision-making process. In addition, our expert panel felt that the seven cues provided were essential factors in formulating treatment plans for patients with early prostate cancer. Despite this, no consultant in our study made significant use of all seven cues across the 70 case scenarios. It is also important to note that few consultants used the cues provided when recommending radical radiotherapy. This is concerning as the cues used in this research were recommended by experts, and indicates that the consultants may be using subjective and personally biased information when advising radical radiotherapy rather than relying on the objective facts.
Redundant cues
Several cues were not used by the majority of the consultants when making decision. These are called 'redundant cues'. Previous studies reviewing JA have also recorded this phenomenon. 11 Furthermore, Kirwan et al. 4 reported that clinicians often felt that they were using all available information when in fact they actually used information very selectively. Surprisingly, in our study the redundant cues were 'patient choice' and 'patient co-morbidity' (thus life expectancy) which is concerning as experts involved in the design of the study felt that these cues provided vital information for decision-making. Furthermore, this is particularly clinically relevant in the light of recent initiatives to promote patient-centred care. As well as fear and distress, patients feel loss of control in their lives and good communication skills and patient choice are essential in relieving the psychological impact of a diagnosis of cancer. This is especially true in early prostate cancer where treatment options may have similar outcomes, but the treatments themselves, and their potential complications, are very different. This study highlights the fundamental point that clinicians, when deciding what they think is best for the patient, may actually ignore what the patient really wants. Clinicians may need to change their practice to prevent patients feeling disempowered, and should enhance their listening skills to ensure that patients agree with and understand the management decisions thereby improving compliance with treatment and overall patient care.
Regarding other redundant cues, patient co-morbidity, and by inference life expectancy, was also rarely used. In the clinical setting, the danger of ignoring co-morbid factors is that some patients will be offered treatment inappropriately and others denied it. This is a particularly important finding as current guidelines suggest that radical treatment should only be offered to patients with localized prostate cancer with a life expectancy of greater than 10 years. 12 Previous work has demonstrated that clinicians are poor at estimating life expectancy with a tendency to underestimate. 10 Perhaps the consultants in this study, acknowledging their difficulty in estimating life expectancy from co-morbidity, have learned to rely on other factors/ cues when making treatment decisions. At medical school we were taught about objective facts that influence disease severity such as PSA and stage but had minimal training in assimilating the effect of multiple co-morbidities on outcome. As clinicians become more senior and experienced in their own specialty, knowledge of other specialties wanes. To resolve this issue we must ensure that clinicians are better trained in the estimation of life expectancy from patient co-morbidities so that patients are not excluded from potentially curative treatment because of age or other discriminating factors. Knowledge of life expectancy is also essential in preventing patients undergoing unnecessary interventions if they are unlikely to live long enough to benefit from them. Discussion of co-morbidities in the MDT setting is essential and this could be aided by the use of an objective measure of life expectancy based on comorbidities. With this in mind and in collaboration with an actuarial statistician and computer programmers, our study centre is designing a user-friendly computer software program to accurately estimate life expectancy using patient co-morbidity-'the Measurement of Actuarial Life Expectancy, MALE'. We hope that the life expectancy data generated from this program will encourage clinicians to be more conscious of this variable when making decisions and enable them to manage patients more appropriately.
Conclusion
This study has revealed inadequacies in the process of clinical decision-making in the management of early prostate cancer. Consultants were not only unreliable in decision-making, but also used few of the available cues when formulating decisions. They often ignored cues such as patient choice and co-morbidity despite the fact that these cues are essential for appropriate decision-making. The results of this study justify the use of the MDT and protocol-driven pathways for patient care to ensure that consistent decisions are made and importantly, that all relevant patient information is used when formulating treatment plans. It is essential to remember that in the MDT setting, clinicians are encouraged to make complex decisions based on paper representations of patient's clinical data, as used in this study. If we are to use patient data in this way, clinicians must be suitably trained in this process to ensure that appropriate clinical decisions are made. Furthermore, inconsistency and poor cue usage may occur in other areas of urology and in fact, many fields of medicine. Additional research is therefore needed to review the clinical decision-making process in general and to assess the role of further education and training in this area.
Consultant decision-making and prostate cancer J Wilson et al
